UK Aesthetics Regulation and Licensing in 2026
UK Aesthetics Regulation & Licensing in 2026
The rules governing Botox, dermal fillers and other non-surgical treatments are being rewritten across the UK. Here is a clear, honest, up-to-date picture of what has actually changed, what is still coming, and what it means whether you are training to enter the field or already practising.
For years, the UK’s booming non-surgical aesthetics industry has carried an uncomfortable paradox: you can have Botox or dermal fillers injected into your face by someone with no medical background and no mandatory qualification, in a setting with no premises licence — yet the same treatments sit at the sharp end of patient-safety concern. That gap is now closing, but not evenly, and not overnight.
2026 is a pivotal year. England has committed to a national licensing scheme but hasn’t switched it on yet. Scotland has passed its own, stricter law. Wales has become the first UK nation to license “special procedures.” And underneath all of it sits a set of rules that already apply today and that too many practitioners misunderstand. This guide separates what is
law now
from what is
coming soon
— and explains what a considered, future-proof approach to training and practice looks like.
This article is a plain-English overview for education, not legal advice. Regulation is moving quickly and differs across England, Scotland, Wales and Northern Ireland. Always check the current position for your nation and your specific procedures, and take professional advice before making business or clinical decisions. Everything below is current to
July 2026
.
01
Why the rules are changing
The non-surgical cosmetic sector has grown enormously, and with it the number of people offering injectable treatments after only a short course — or none at all. Dermal fillers, in particular, occupy a striking regulatory blind spot: unlike botulinum toxin, most fillers are classed as medical
devices
rather than medicines, so they can be bought and administered without a prescription. Complications — from vascular occlusion and blindness to serious infection — are rare in skilled hands but can be devastating when they occur.
Public and political pressure intensified after the death of Alice Webb in 2024, widely reported as the first UK death linked to a non-surgical “liquid” Brazilian butt lift. Patient-safety organisations such as Save Face have documented hundreds of cases of harm. The direction of travel is now firmly towards
minimum training standards, premises requirements and, for the riskiest procedures, restriction to qualified healthcare professionals.
02
What the law actually is right now
Before looking at what’s coming, it’s worth being precise about what already binds you in 2026 — because these rules apply today, regardless of the new licensing schemes.
Botulinum toxin is a prescription-only medicine
Botox and other botulinum toxin products are prescription-only medicines (POMs). They can only be lawfully prescribed by a registered prescriber — a doctor, dentist, or an independent-prescribing nurse or pharmacist — for a specific, named patient, following a
face-to-face assessment
. Remote prescribing of injectable cosmetic POMs (for example, prescribing over video or after a phone call) is not compliant with professional regulator guidance. A non-prescribing injector must work with a prescriber who has personally assessed the patient.
Treating under-18s is illegal in England
The
Botulinum Toxin and Cosmetic Fillers (Children) Act 2021
came into force on
1 October 2021
. It makes it an offence in England to administer botulinum toxin or cosmetic fillers by injection to a person under 18 for cosmetic purposes, or to arrange or book such treatment. Narrow exceptions exist only where a registered health professional provides treatment approved by a doctor for a genuine medical reason.
CQC registration is only for certain activities — for now
In England, standard facial Botox and dermal fillers are generally
not
within the Care Quality Commission’s list of “regulated activities,” so most facial-aesthetics clinics do not currently need CQC registration. Registration is triggered by specific regulated activities (for example, some medical treatments) and by the highest-risk procedures. This will change as the new scheme develops, so don’t treat today’s position as permanent.
Advertising, product and data rules still apply
Prescription-only medicines like Botox cannot be advertised to the public — you cannot promote “Botox” by name in consumer marketing. Advertising Standards Authority rules, medical-device requirements for fillers, insurance obligations and data-protection law all apply now, independently of any licensing scheme.
03
England’s incoming licensing scheme
The legal foundation is already in place:
Section 180 of the Health and Care Act 2022
gives the Secretary of State the power to create a licensing scheme for non-surgical cosmetic procedures in England. What has been missing is the detail — and that is what the Government has been consulting on.
A major public consultation ran in
2023
and drew almost 12,000 responses. On
7 August 2025
, the Government published its response, confirming its intention to introduce a two-part system: a
local-authority licensing scheme
for lower- and medium-risk procedures, and
CQC regulation
for the highest-risk procedures, which would be restricted to qualified healthcare professionals in registered premises. Alongside it, the Government announced it would prioritise legislation on the most dangerous procedures first, with a further public consultation on those high-risk restrictions.
As of mid-2026, England’s licensing scheme is
confirmed in principle but not yet in force.
The Government has stated its direction and the tiering model, but the precise procedures, qualification standards, supervision rules and start date are still being worked out through further consultation and parliamentary scrutiny. In other words: the shape is clear, the switch hasn’t been flipped, and the smart move is to train and operate as if it already has.
04
The red / amber / green tiers
At the heart of England’s proposals is a risk-based “RAG” classification. Exactly which procedure lands in which tier is still being finalised, but the framework is as follows:
Lower risk
Procedures with the lowest risk profile (for example, certain superficial treatments). Any practitioner who is licensed and meets the agreed training, hygiene and insurance standards would be able to perform them, under local-authority licensing.
Medium risk
Expected to include
botulinum toxin and most dermal fillers.
These could be performed by suitably trained practitioners, but non-healthcare practitioners would need
oversight from a regulated healthcare professional
(and, for toxin, a prescriber). Licensed by local authorities to defined standards.
Highest risk
The most dangerous procedures — such as non-surgical (liquid) Brazilian butt lifts and filler injections into the breasts or genitals. These would be restricted to
qualified healthcare professionals working in CQC-registered premises
, and are the Government’s first priority for legislation.
05
The four nations at a glance
Aesthetics regulation is devolved, so the picture genuinely differs depending on where you practise. This is one of the most misunderstood parts of the whole subject.
| Nation | Where it stands in 2026 | What it means in practice |
|---|---|---|
| England | Licensing scheme confirmed under the Health and Care Act 2022; Government response published Aug 2025; RAG tiers proposed; further consultation on high-risk procedures. Not yet in force. | Local-authority licence expected for Botox/fillers; CQC for high-risk. Prepare now; watch for the start date. |
| Scotland | The Non-surgical Procedures (Scotland) Bill was passed by the Scottish Parliament on 17 March 2026, awaiting Royal Assent. Expected to take effect around 2027. | The strictest approach: in-scope procedures to be delivered by healthcare professionals in Healthcare Improvement Scotland–registered premises. |
| Wales | First UK nation to launch a mandatory licensing scheme for “special procedures” under the Public Health (Wales) Act 2017 and the Special Procedure Licences (Wales) Regulations 2024, rolling out from 2025. | Covers tattooing, semi-permanent make-up, body piercing, electrolysis and acupuncture. Botox and fillers are not in scope yet, though there is pressure to add them. |
| Northern Ireland | No dedicated statutory licensing scheme for non-surgical cosmetic injectables at present. | Relies on existing professional, medicines and premises rules; expected to follow the wider UK direction over time. |
Because timelines and scope are still shifting, always confirm the live position with the relevant authority for your nation before relying on it.
06
Who regulates what today
Even without a single licensing scheme, several bodies already shape lawful practice. Understanding who does what is half the battle.
| Body | Role in aesthetics |
|---|---|
| GMC / NMC / GDC / GPhC | Regulate doctors, nurses, dentists and pharmacists. If you hold one of these registrations, your regulator’s standards and prescribing rules apply to your aesthetic work. |
| CQC | Regulates specific “regulated activities” and premises in England — currently the higher-risk end, expanding under the new scheme. |
| Local authorities | Will administer licensing for green and amber procedures in England; already run “special treatment” and special-procedure licensing in parts of the UK. |
| MHRA | Regulates medicines (botulinum toxin) and medical devices (most fillers), including safety and marketing. |
| JCCP & CPSA | The Joint Council for Cosmetic Practitioners maintains a voluntary, PSA-accredited register of practitioners; the Cosmetic Practice Standards Authority sets the underpinning standards. |
| ASA | Enforces advertising rules — including the ban on advertising prescription-only medicines such as Botox to the public. |
07
If you’re thinking about training
If you’re considering a career in aesthetics, the changing regulation is genuinely good news — it rewards people who train properly and raises the value of a recognised qualification. Here’s how to think about entering the field so that you’re building on solid ground rather than sand.
There is no shortcut worth taking
You may see one-day “Botox and filler” courses promising you can start injecting immediately. Under the direction regulation is heading, that model is exactly what’s being designed out. The qualifications and standards being discussed point towards structured, assessed training — with accredited foundation courses and
Level 7
postgraduate qualifications increasingly seen as the benchmark, aligned to the Health Education England / JCCP education and training framework.
Understand the medical backbone
Because botulinum toxin is prescription-only, most non-prescribing practitioners will always need a working relationship with a prescriber. If you don’t come from a medical background, choose training that teaches you not just injection technique but anatomy, complication management, consent, and how the prescribing relationship works in practice.
Choose training that future-proofs you
Ask any academy: is the training accredited? Does it map to recognised standards and support JCCP registration? Does it cover complications and medical emergencies, not just technique? Is there hands-on, supervised practice on real patients? These are the features that will still matter — and may become mandatory — once statutory licensing arrives.
If a course’s main selling point is speed and low cost rather than depth, accreditation and clinical safety, treat that as a warning sign. The market is moving towards higher standards; training to yesterday’s floor is a poor investment.
08
If you’re already practising
If you already inject — whether you’re a nurse, doctor, dentist, pharmacist or an experienced non-medical practitioner — the priority is to make sure your current practice is watertight and to position yourself ahead of statutory licensing rather than behind it.
Get your prescribing relationship right
Ensure every toxin patient is assessed face-to-face by your prescriber before treatment, with clear records. If you’ve relied on remote prescribing arrangements, review them now — they don’t meet regulator expectations and are an obvious early target for enforcement.
Document, insure and consent properly
Robust consent, thorough clinical records, appropriate medical indemnity and product-liability insurance, and clear complication protocols are already expected of good practice and will almost certainly feature in licensing standards. If your paperwork wouldn’t stand up to scrutiny, fix it before it has to.
Register voluntarily — before it’s mandatory
Joining the JCCP register and working to CPSA standards is voluntary today, but it demonstrates you already meet recognised benchmarks. Practitioners who are on a PSA-accredited register and trained to Level 7 are best placed for whatever the amber-tier supervision and qualification rules turn out to be.
Know your nation’s trajectory
If you practise in Scotland, plan now for delivery within HIS-registered premises and healthcare-professional involvement once the new law takes effect. In England, watch for the licensing start date and the high-risk consultation outcome. In Wales, check whether your services touch the special-procedures scheme.
09
Your 2026 compliance checklist
A practical snapshot of what good, defensible practice looks like right now — and what to have in place before statutory licensing lands.
|
✓
|
Accredited training appropriate to every procedure you offer, ideally progressing towards Level 7 |
|
✓
|
A prescriber who assesses each toxin patient face-to-face, with documented prescriptions |
|
✓
|
Never treat under-18s for cosmetic purposes (England) — and apply the same standard as best practice everywhere |
|
✓
|
Full written consent, medical history and clinical records for every patient |
|
✓
|
Current medical indemnity and product-liability insurance |
|
✓
|
Written complication and medical-emergency protocols, including access to hyaluronidase for filler emergencies |
|
✓
|
Correct advertising — no promotion of prescription-only medicines by name to the public |
|
✓
|
Voluntary JCCP registration and adherence to CPSA standards |
|
✓
|
A plan for your nation’s incoming rules (England licensing, Scotland’s new law, Wales special procedures) |
10
Key dates & timeline
|
1 October 2021
Under-18 ban takes effect (England)
The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it an offence to give under-18s toxin or filler for cosmetic purposes in England.
|
|
|
July 2022
Health and Care Act 2022 becomes law
Section 180 gives ministers the power to create a licensing scheme for non-surgical cosmetic procedures in England.
|
|
|
Sept–Oct 2023
England consultation
The Government consults on the licensing scheme and the RAG tiering model, receiving almost 12,000 responses.
|
|
|
August 2025
Government response & safety crackdown
England confirms its intention to license lower/medium-risk procedures via local authorities and regulate high-risk procedures via CQC, prioritising the most dangerous treatments first.
|
|
|
17 March 2026
Scotland passes its Bill
The Scottish Parliament passes the Non-surgical Procedures Bill, requiring healthcare-professional delivery in HIS-registered premises. Royal Assent and implementation (expected around 2027) to follow.
|
|
|
2026 onwards
England’s next steps
Further consultation on high-risk procedures, development of qualification and supervision standards, and secondary legislation before the licensing scheme comes into force. Exact dates still to be confirmed.
|
11
Frequently asked questions
Not a single national licence yet, in England. The Government has confirmed it will introduce one under the Health and Care Act 2022 using a red/amber/green model, but it isn’t in force and further consultation is expected. Meanwhile, botulinum toxin remains prescription-only (requiring a prescriber and a face-to-face assessment), and treating under-18s for cosmetic purposes is illegal in England. Scotland has passed its own law, expected to take effect around 2027, requiring healthcare-professional delivery in registered premises.
It’s the three-tier, risk-based classification proposed for England. Green = lower-risk procedures for any suitably licensed practitioner; Amber = medium-risk procedures such as Botox and fillers, with healthcare-professional oversight for non-medics; Red = highest-risk procedures (like liquid BBLs and intimate-area filler) restricted to healthcare professionals in CQC-registered premises.
In England today, standard facial Botox and dermal fillers generally fall outside the CQC’s regulated activities, so most facial-aesthetics clinics don’t currently need CQC registration. It’s triggered by specific regulated activities and the highest-risk procedures — and this is expected to change under the new scheme, so keep checking your specific services.
No — the JCCP register is voluntary and accredited by the Professional Standards Authority. It isn’t a legal requirement yet, but it demonstrates that you meet recognised education and standards, and it’s widely seen as best practice ahead of statutory regulation.
In England, yes — for now — provided the medicines, advertising, age and insurance rules are met and a prescriber assesses toxin patients. Under the proposed amber tier, non-healthcare practitioners would need oversight from a regulated healthcare professional. Scotland is moving to require healthcare-professional delivery for in-scope procedures. The direction is clearly towards greater medical involvement.
There’s no single mandatory qualification in England yet, but accredited foundation training progressing to a Level 7 postgraduate qualification — aligned to the HEE/JCCP framework, with strong anatomy and complication-management content — is the benchmark most likely to keep you compliant as licensing arrives.
At PHP Training Academy we build accredited, clinically rigorous aesthetics training designed around where the profession is going — not where it used to be. Whether you’re starting out or upskilling to Level 7, we’ll help you train safely, confidently and compliantly.
This article is for general information and education only and does not constitute legal, medical or regulatory advice. Aesthetics regulation is devolved and changing rapidly; details, scope and timelines may have changed since publication (July 2026). Always confirm the current requirements with the relevant regulator or authority for your nation and your specific procedures, and take appropriate professional advice before making clinical or business decisions.
| 1 | The regulation of non-surgical cosmetic procedures in England — House of Commons Library briefing (CBP-10331) |
| 2 | Licensing of non-surgical cosmetic procedures in England: consultation response — GOV.UK, 7 August 2025 |
| 3 | Crackdown on unsafe cosmetic procedures to protect the public — GOV.UK, 6 August 2025 |
| 4 | Health and Care Act 2022, section 180 — legislation.gov.uk |
| 5 | Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 — GOV.UK guidance |
| 6 | Non-surgical Procedures (Scotland) Bill — Scottish Parliament |
| 7 | Special Procedure Licences (Wales) Regulations 2024 — legislation.gov.uk / GOV.WALES |
| 8 | Joint Council for Cosmetic Practitioners (JCCP) — jccp.org.uk |
